NCT00488618 - Study Evaluating Cariprazine (RGH-188) in the Treatment of Patients With Acute Mania | Biotech Hunter

Enrollment

238

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions

Bipolar Disorder

Interventions

DRUG

Cariprazine (RGH-188)

Cariprazine 3 mg - 12 mg oral administration, once per day.

DRUG

Placebo

Dose-matched placebo oral administration, once per day.

Trial Locations (1)

For information regarding investigative sites, contact Forest Professional Affairs, St Louis